Cervical cancer was the second most common cancer of women in Thailand after breast cancer. Incidence of cervical cancer in Thailand was 23.4 in 100,000 (Ferlay et al., 1998). Cervical cancer mortality rate was rising from 0.66 0.94% between 2011 and 2014 (Department of Disease Control, Ministry of Public Health, 2015). Cervical cancer is preventable by screening for precancerous lesions. Avail...

Cervical cancer is the fourth leading cause of cancer-related death in women worldwide, with 90% of cases occurring in low- and middle-income countries (LMICs). There has been a global effort to increase access to affordable screening in these settings; however, a corresponding increase in availability of effective and inexpensive treatment modalities for ablating or excising precancerous lesio...

The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection causes >550,000 cases of cervical and anogenital cancer worldwide annually. Infection also causes precancerous lesions and genital warts. HPV types 16 and 18 cause approximately 70% of HPV-related cancers, and HPV types 6 and 11 cause approximately 90% of cases of genital warts. A quadrivalent vaccine for HPV t...

Background: Female genital schistosomiasis is a gynecological disease caused by Schistosoma haematobium. The uterine cervix appears to be the most affected area with cases found in sub-Saharan Africa. Though both males and females can affected, consequences of are more pronounced reported increased risk HIV transmission malignancy female genitalia. shares similarities presentation those cervica...

Background: Cervical cancer presents as major cause of morbidity and mortality especially in developing countries like India. Various screening programs are implemented for its early detection and treatment, which makes it imperative to have a reliable screening investigation for wider application. Objective : TO evaluate the role of Liquid base cytology and Colposcopy and compare their efficac...

BACKGROUND Curaçao is a Dutch-Caribbean Island located in a high-risk area for cervical cancer.Prior to introduction of a prophylactic human papillomavirus (HPV) vaccine, knowledge of the prevalence of high-risk HPV vaccine genotypes (HPV16, 18, 31, 33, 45, 52 and 58) in cervical (pre)cancer is required. OBJECTIVE To investigate the prevalence of HPV genotypes in invasive cervical cancers (IC...

Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70% of all cervical cancers. Types 6 and 11 do not contribute to the incidence of high-grade dysplasias (precancerous lesions) or cervical cancer...

High-risk human papillomaviruses (HPV), such as HPV-16, are etiologic agents of a variety of anogenital and oral malignancies, including nearly all cases of cervical cancer. Cervical cancers arising in transgenic mice that express HPV-16 E7 in an inducible manner require the continuous expression of E7 for their maintenance. However, in HPV-associated cancers in vivo, E6 and E7 invariably are c...